Aplikace z oblasti Farmaceutická analýza se zaměřením na LC/MS/MS - strana 8
Otevřít dokument Ultra-Trace Quantification of N-Nitroso-desmethyl-sumatriptan with Interference Resolution Using LC–TQ
Ultra-Trace Quantification of N-Nitroso-desmethyl-sumatriptan with Interference Resolution Using LC–TQ
LC/MS, LC/MS/MS, LC/QQQ
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System
Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument Rapid LC-MS/MS compound method development and sample analysis for DMPK workflows
Rapid LC-MS/MS compound method development and sample analysis for DMPK workflows
LC/MS, LC/MS/MS, LC/QQQ, Software
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ, Software
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument Development of timsMRMS: A Gated-TIMS FT-ICR MS instrument to decipher isomeric content of complex organic mixtures
Development of timsMRMS: A Gated-TIMS FT-ICR MS instrument to decipher isomeric content of complex organic mixtures
LC/MS, LC/MS/MS, Iontová mobilita, LC/Ultra-HRMS, MALDI, MS Imaging
Instrumentace
LC/MS, LC/MS/MS, Iontová mobilita, LC/Ultra-HRMS, MALDI, MS Imaging
Výrobce
Bruker
Zaměření
Farmaceutická analýza
Otevřít dokument Higher Throughput Intact Mass Confirmation and Impurity Screening of GLP-1 Analogues Using Multi-Reflecting TOF Technology and INTACT Mass 1.9 Application
Higher Throughput Intact Mass Confirmation and Impurity Screening of GLP-1 Analogues Using Multi-Reflecting TOF Technology and INTACT Mass 1.9 Application
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Reversed-Phase LC-MS Analysis of Low- Abundance Impurities in a GLP-1a Therapeutic Using a Charged Surface 230Å Superficially Porous Phenyl-Hexyl Column
Reversed-Phase LC-MS Analysis of Low- Abundance Impurities in a GLP-1a Therapeutic Using a Charged Surface 230Å Superficially Porous Phenyl-Hexyl Column
Spotřební materiál, LC kolony, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
Spotřební materiál, LC kolony, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument A Holistic View of GLP 1R Agonist–Mediated Cellular Response Revealed Through Orthogonal Technologies
A Holistic View of GLP 1R Agonist–Mediated Cellular Response Revealed Through Orthogonal Technologies
LC/MS, LC/MS/MS, LC/QQQ
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument LC/MS Characterization of GLP-1 Receptor Agonist Oligomers and Other Elusive Impurities
LC/MS Characterization of GLP-1 Receptor Agonist Oligomers and Other Elusive Impurities
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument Effect of column chemistry, temperature, inert flow path, and mobile phase on the separation of GLP-1 peptides and their impurities
Effect of column chemistry, temperature, inert flow path, and mobile phase on the separation of GLP-1 peptides and their impurities
LC/MS, LC/MS/MS, Spotřební materiál, LC kolony, LC/QQQ
Instrumentace
LC/MS, LC/MS/MS, Spotřební materiál, LC kolony, LC/QQQ
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument Integrated LC/UV and LC/MS Workflows for Impurity and Degradation Characterization of GLP-1 Agonists
Integrated LC/UV and LC/MS Workflows for Impurity and Degradation Characterization of GLP-1 Agonists
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, HPLC, Spotřební materiál, LC kolony
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, HPLC, Spotřební materiál, LC kolony
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
